none

PRELIMINARY BID FOR AUSSIE CANCER DRUG

01-03-2018
by 
in 

International pharmaceuticals company Merck has made an aquisition bid for Aussie firm Viralytics, after their drug Cavatak showed promising results in preliminary treatments. 

Viralytics CEO Malcolm McColl said the drug was actually a type of common cold virus that had been found to kill cancer cells, and that Cavatak was most effective when used in conjunction with Merck's immune-boosting drug Keytruda.

As a company, Viralytics centers is research around the development and commercialisation of treatments that harness the power of specific viruses to infect and kill cancer cells.

"The way we tackle cancer now is quite different to ten years ago," said McColl.

"People are looking to turn the patient's immune system against the cancer and that's really what Cavatak is doing."

Even before completion of the bid, trials have begun for testing Cavatak with Merck's Keytruda to treat melanoma, prostate, lung and bladder cancers.

Investors and the Viralytics board have positive views on the bid, viewing it as a strong opportunity for the Australian-based Viralytics to expand its reach and impact. 

"It's a good deal but we have done the hard yards on this company," said Troy Cairns, director of Viralytics investor Quest. 

"It's valuable, but its not easy to to commercialise things in Australia, and Merck is a good partner."

"Merck has done a lot of diligence on the program both in terms of the clinical and manufacturing data and are obviously fully satisfied and convinced that there's a great potential for Cavatak to help cancer patients," Mr McColl said.

 

Related news & editorials

  1. 12.11.2018
    12.11.2018
    by      In
    Energy Vault has developed a novel solution to storage for renewable energy plants that involves neither batteries nor water.
    The Energy Vault system is based on the fundamental physics of potential and kinetic energy, and uses a proprietary, cloud-based software platform to operate a newly... Read More
  2. 07.11.2018
    07.11.2018
    by      In
    With a combination of its industry-leading fans and energy-efficient lighting products, Big Ass is improving working conditions in Australia and around the globe.
    Blazing Queensland temperatures and humidity were creating uncomfortable working conditions at XL Service Bodies, an industry-leading... Read More
  3. 07.11.2018
    07.11.2018
    by      In
    ABB has thrown its weight behind the OPC Foundation in its bid to define the worldwide industrial interoperability standard. The new Open Platform Communication Unified Architecture (OPC UA) standard has the potential to enable industrial players to unlock the full potential of Industry 4.0.
    OPC UA... Read More
  4. 01.11.2018
    01.11.2018
    by      In
    Austech 2019 appears to be on course to be a record-breaking show, with advance bookings from exhibitors far surpassing expectations, and high levels of interest from across the industry.
    Scheduled to take place at Melbourne Convention and Exhibition Centre from 14th to 17th May 2019, Austech is... Read More